Dexamphetamine—a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline make it a strong buy for 2025.

Among 2024’s notable new drugs were three approvals for antibiotic therapies: Allecra Therapeutics’ Exblifep (cefepime and enmetazobactam), Basilea Pharmaceutica’s Zevtera (ceftobiprole ...

Avadel’s commercial product, LUMRYZ TM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or EDS in patients 7 ...

Narcolepsy is generally treated with medication. Some medications are effective for sleepiness, some are effective for cataplexy, some are effective for other associated symptoms, and some are ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

E-2086 is under clinical development by Eisai and currently in Phase I for Narcolepsy. According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR) indication ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, with 66 percent of people in ...